Investing in Health | May 9, 2022

LeapFrog leads Redcliffe’s $61 million raise for health diagnostics in India

Roodgally Senatus
ImpactAlpha Editor

Roodgally Senatus

ImpactAlpha, May 9 — Noida-based Redcliffe has raised $61 million to provide diagnostics for non-communicable diseases, such as heart disease, cancer and diabetes, online and via 22 labs across India. Such diseases are responsible for over six million deaths in India each year. With early diagnosis, patients can tap more affordable treatment options, and lower their risk for hospitalization.

“Preventative medicine is the future of health in India, helping to empower the average Indian with the information they need to take charge of their health and wellbeing,” says Redcliffe’s Dheeraj Jain.

Health access

LeapFrog Investments led the round, with participation from Healthsquad, Schroders, Chiratae Ventures and others. Jain said the investment will help the company meet its goal to reach more than 500 million Indians in five years.

The company is looking to expand in India’s tier 2, 3 and 4 cities, and “remote areas that are too often difficult to reach with existing infrastructure,” said Chiratae’s Ranjith Menon.